Play all audios:
Access through your institution Buy or subscribe Use of high-dose-rate brachytherapy as monotherapy for the treatment of intermediate-risk and high-risk prostate cancer is safe and
effective, according to researchers in Japan. Low-dose-rate permanent seed brachytherapy and temporary high-dose-rate brachytherapy are widely used for the treatment of early and locally
advanced prostate cancer. High-dose-rate brachytherapy has historically been used in combination with external beam radiation therapy (EBRT), but more recently, interest has grown in the use
of high-dose-rate brachytherapy as a monotherapy. This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this
journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now
Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer
support REFERENCES * Yoshioka, Y. _ et al_. High-dose-rate brachytherapy as monotherapy for intermediate- and high-risk prostate cancer: clinical results for a median eight-year follow-up.
_Int. J. Radiat. Oncol. Biol. Phys._ 10.1016/j.ijrobp.2015.05.044 Download references Authors * Rebecca Kelsey View author publications You can also search for this author inPubMed Google
Scholar RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Kelsey, R. High-dose-rate brachytherapy as monotherapy in prostate cancer. _Nat Rev Urol_ 12, 359
(2015). https://doi.org/10.1038/nrurol.2015.151 Download citation * Published: 23 June 2015 * Issue Date: July 2015 * DOI: https://doi.org/10.1038/nrurol.2015.151 SHARE THIS ARTICLE Anyone
you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the
Springer Nature SharedIt content-sharing initiative